Papers

1

Total Citations

12

H-Index

1

About

Dr. Chongwei Bi is a biomedical researcher whose work centers on infectious disease diagnostics, genomic surveillance, and the democratization of molecular biology tools. His most notable contribution is the development of an open-source, automated, and cost-effective platform for COVID-19 diagnosis and rapid portable genomic surveillance using nanopore sequencing. This platform, detailed in a 2023 publication (12 citations), addresses critical global health needs by enabling high-throughput RNA extraction with locally produced reagents and minimal reliance on fragile supply chains. By prioritizing accessibility and automation, Dr. Bi’s work empowers laboratories in resource-limited settings to conduct both diagnosis and real-time viral tracking. His research exemplifies how engineering principles can be applied to public health challenges, reducing barriers to cutting-edge genomic technologies. With a focus on scalable, low-cost solutions, Dr. Bi is helping to reshape pandemic preparedness and infectious disease monitoring, making advanced molecular surveillance a practical reality for diverse global communities.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
An open-source, automated, and cost-effective platform for COVID-19 diagnosis and rapid portable genomic surveillance using nanopore sequencing
12 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: King Abdullah University of Science and Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 70 days ago